Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

QN523 

🥰Excellent
Catalog No. T64374Cas No. 878581-60-3

QN523 represents a novel scaffold with drug-like properties, showing potent in vitro cytotoxicity in a panel of 12 cancer cell lines. QN523 shows significant in vivo efficacy in a pancreatic cancer xenograft model. Autophagy is a major mechanism of action.

QN523 

QN523 

🥰Excellent
Purity: 97.26%
Catalog No. T64374Cas No. 878581-60-3
QN523 represents a novel scaffold with drug-like properties, showing potent in vitro cytotoxicity in a panel of 12 cancer cell lines. QN523 shows significant in vivo efficacy in a pancreatic cancer xenograft model. Autophagy is a major mechanism of action.
Pack SizePriceAvailabilityQuantity
1 mg$30In Stock
5 mg$68In Stock
10 mg$107In Stock
25 mg$218In Stock
50 mg$343In Stock
100 mg$493In Stock
200 mg$685In Stock
1 mL x 10 mM (in DMSO)$65In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "QN523 "

Select Batch
Purity:97.26%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
QN523 represents a novel scaffold with drug-like properties, showing potent in vitro cytotoxicity in a panel of 12 cancer cell lines. QN523 shows significant in vivo efficacy in a pancreatic cancer xenograft model. Autophagy is a major mechanism of action.
In vitro
QN523 showed significant cytotoxicity with IC50 values ranging from 0.1 to 5.7 μM across 12 cell lines. QN523 at 0.5 μM and gemcitabine at 0.1 μM arrested MIA PaCa-2 cells in the S-phase following 24 and 48 h treatment[1].
In vivo
In NOD/SCID mice of MIA PaCa-2 xenografts, QN523 at 10 mg/kg (intraperitoneal administration) shows no significant delay in tumor growth from day 1 to day 9. QN523 at 20 mg/kg from day 10 and continued until day 44 delayed growth of the MIA PaCa-2 xenograft starting from day 17. On day 44 80% inhibition of tumor growth was observed. No symptoms of gross toxicity such as weakness, weight loss or lethargy were observed in the QN523 treatment group[1].
Chemical Properties
Molecular Weight250.26
FormulaC14H10N4O
Cas No.878581-60-3
SmilesO=C(Nc1cccc2cccnc12)c1cnccn1
Storage & Solubility Information
StorageShipping with blue ice.
Solubility Information
DMSO: 16.2 mg/mL (64.7 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.9958 mL19.9792 mL39.9584 mL199.7922 mL
5 mM0.7992 mL3.9958 mL7.9917 mL39.9584 mL
10 mM0.3996 mL1.9979 mL3.9958 mL19.9792 mL
20 mM0.1998 mL0.9990 mL1.9979 mL9.9896 mL
50 mM0.0799 mL0.3996 mL0.7992 mL3.9958 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy QN523  | purchase QN523  | QN523  cost | order QN523  | QN523  chemical structure | QN523  in vivo | QN523  in vitro | QN523  formula | QN523  molecular weight